Todenhöfer, Tilman

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 10.

Journal Article

Christensen, Emil; Wyatt, Alexander W; Galsky, Matthew D; Grivas, Petros; Seiler, Roland; Nawroth, Roman; Goebell, Peter J; Schmitz-Drager, Bernd J; Williams, Stephen B; Black, Peter C; Kamat, Ashish M; Todenhöfer, Tilman; Dyrskjøt, Lars (2023). IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer. Urologic oncology - seminars and original investigations, 41(7), pp. 318-322. Elsevier 10.1016/j.urolonc.2022.11.008

Ahmed, Mohamed E; Todenhöfer, Tilman; Karnes, R Jeffrey; Seiler, Roland (2022). Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers. European urology focus, 8(3), pp. 663-666. Elsevier 10.1016/j.euf.2022.06.009

Williams, Stephen B; Black, Peter C; Dyrskjøt, Lars; Seiler, Roland; Schmitz-Dräger, Bernd; Nawroth, Roman; Todenhöfer, Tilman; Kamat, Ashish M; Goebell, Peter J (2020). Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420-33: A Statement from the International Bladder Cancer Network. European urology, 77(4), e105-e106. Elsevier 10.1016/j.eururo.2019.11.011

Todenhöfer, Tilman; Seiler, Roland (2019). Molecular subtypes and response to immunotherapy in bladder cancer patients. Translational andrology and urology, 8(Suppl 3), S293-S295. AME Publishing Company 10.21037/tau.2019.06.21

Todenhöfer, Tilman; Miernik, Arkadiusz; Seiler, Roland (2019). [High-throughput molecular analysis of urothelial carcinoma: potential clinical applications]. Aktuelle Urologie, 50(1), pp. 84-93. Thieme 10.1055/a-0755-7284

Todenhöfer, Tilman; Struss, Werner J; Seiler, Roland; Wyatt, Alexander William; Black, Peter C (2018). Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer. Bladder cancer, 4(1), pp. 19-29. IOS Press 10.3233/BLC-170140

Seiler, Roland; Ashab, Hussam Al Deen; Erho, Nicholas; van Rhijn, Bas W G; Winters, Brian; Douglas, James; Van Kessel, Kim E; Fransen van de Putte, Elisabeth E; Sommerlad, Matthew; Wang, Natalie Q; Choeurng, Voleak; Gibb, Ewan A; Palmer-Aronsten, Beatrix; Lam, Lucia L; Buerki, Christine; Davicioni, Elai; Sjödahl, Gottfrid; Kardos, Jordan; Hoadley, Katherine A; Lerner, Seth P; ... (2017). Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy. European urology, 72(4), pp. 544-554. Elsevier 10.1016/j.eururo.2017.03.030

Seiler, Roland; Black, Peter C; Thalmann, George; Stenzl, Arnulf; Todenhöfer, Tilman (2017). Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer? Urologic oncology - seminars and original investigations, 35(7), 458.e1-458.e7. Elsevier 10.1016/j.urolonc.2017.01.024

Seiler, Roland; Oo, Htoo Zarni; Tortora, Davide; Clausen, Thomas M; Wang, Chris K; Kumar, Gunjan; Pereira, Marina Ayres; Ørum-Madsen, Maj S; Agerbæk, Mette Ø; Gustavsson, Tobias; Nordmaj, Mie A; Rich, Jamie R; Lallous, Nada; Fazli, Ladan; Lee, Sherry S; Douglas, James; Todenhöfer, Tilman; Esfandnia, Shaghayegh; Battsogt, Dulguun; Babcook, John S; ... (2017). An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer. European urology, 72(1), pp. 142-150. Elsevier 10.1016/j.eururo.2017.03.021

Gakis, Georgios; Efstathiou, Jason A; Daneshmand, Siamak; Keegan, Kirk A; Clayman, Rebecca H; Hrbacek, Jan; Ali-El-Dein, Bedeir; Zaid, Harras B; Schubert, Tina; Mischinger, Johannes; Todenhöfer, Tilman; Galland, Sigolene; Olugbade, Kola; Rink, Michael; Fritsche, Hans-Martin; Burger, Maximilian; Chang, Sam S; Babjuk, Marko; Thalmann, George; Stenzl, Arnulf; ... (2016). Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urologia internationalis, 97(2), pp. 134-141. Karger 10.1159/000448335

This list was generated on Thu Apr 18 16:32:36 2024 CEST.
Provide Feedback